Braveheart Investment Group plc Results of customer trials by Pharm2Farm Limited
19 Septiembre 2019 - 1:02AM
RNS Non-Regulatory
TIDMBRH
Braveheart Investment Group plc
19 September 2019
19 September 2019
Braveheart Investment Group plc
("Braveheart" or the "Group")
Results of customer trials by Pharm2Farm Limited
Braveheart Investment Group plc (AIM: BRH), the fund management
and strategic investment group, is pleased to report that
Pharm2Farm Limited ("Pharm2Farm"), an investee company in which
Braveheart has a 33 per cent. interest has completed product trials
with Griin Agriculture Co. ("Griin") in Korea. In these trials,
Griin used its proprietary vertical hydroponic system, designed to
grow the herb basil intensively in indoor, inner city
locations.
The Korean team compared plants grown indoors, under controlled
conditions. Plants grew much faster and had an improved taste when
Pharm2Farm nanoparticles were added to their nutrient feeds.
Over a 20 day harvesting period, the treated plants produced 33
per cent. more leaves with more intense taste than the untreated
plants. Griin sells the basil to local shops and restaurants, who
value the high quality, freshness, low miles and eco-friendly
nature. Customers appreciate that fresh vegetables taste better and
research shows that some produce loses more than 50 per cent. of
its nutrition within days of harvesting.
Trace minerals, such as iron, copper, silicon, are essential for
healthy plant growth, but historically they have been difficult to
incorporate into a fertilizer in a form which can be readily taken
up by plants.
Pharm2Farm's coated nanoparticle technology, has been
demonstrated to dramatically increase the bioavailability of trace
minerals in plant feeds applicable to all areas of the farming
market.
For further information:
Braveheart Investment Group plc Tel: 01738 587555
Trevor Brown, Chief Executive Officer
Allenby Capital Limited (Nominated Adviser Tel: 020 3328 5656
and Joint Broker)
David Worlidge / Nicholas Chambers
Peterhouse Capital Limited (Joint Broker) Tel: 020 7469 0936
Heena Karani / Lucy Williams
About RNS Reach Announcements
This is an RNS Reach announcement. RNS Reach is an investor
communication service aimed at assisting listed and unlisted
(including AIM quoted) companies to distribute media only /
non-regulatory news releases into the public domain. Information
required to be notified under the AIM Rules for Companies, Market
Abuse Regulation or other regulation would be disseminated as an
RNS regulatory announcement and not on RNS Reach.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NRAGGUWPBUPBGQR
(END) Dow Jones Newswires
September 19, 2019 02:02 ET (06:02 GMT)
Braveheart Investment (LSE:BRH)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Braveheart Investment (LSE:BRH)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024